➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Medtronic
Express Scripts
Baxter
Harvard Business School
McKinsey

Last Updated: April 10, 2021

DrugPatentWatch Database Preview

THYQUIDITY Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

When do Thyquidity patents expire, and what generic alternatives are available?

Thyquidity is a drug marketed by EMP and is included in one NDA. There is one patent protecting this drug.

This drug has eleven patent family members in eleven countries.

The generic ingredient in THYQUIDITY is levothyroxine sodium. There are ten drug master file entries for this compound. Thirty-seven suppliers are listed for this compound. Additional details are available on the levothyroxine sodium profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Thyquidity

A generic version of THYQUIDITY was approved as levothyroxine sodium by MYLAN on June 5th, 2002.

  Start Trial

Summary for THYQUIDITY
International Patents:11
US Patents:1
Applicants:1
NDAs:1
Suppliers / Packagers: 1
Formulation / Manufacturing:see details
Drug Prices: Drug price information for THYQUIDITY
What excipients (inactive ingredients) are in THYQUIDITY?THYQUIDITY excipients list
DailyMed Link:THYQUIDITY at DailyMed
Drug patent expirations by year for THYQUIDITY
Drug Prices for THYQUIDITY

See drug prices for THYQUIDITY

Pharmacology for THYQUIDITY
Drug Classl-Thyroxine

US Patents and Regulatory Information for THYQUIDITY

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Emp THYQUIDITY levothyroxine sodium SOLUTION;ORAL 214047-001 Nov 30, 2020 RX Yes Yes   Start Trial   Start Trial Y   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Colorcon
Mallinckrodt
Johnson and Johnson
Express Scripts
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.